Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours

Clinical trial NCT01861496 · COMPLETED

Trial details

NCT number: NCT01861496
Sponsor: Allarity Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Phase 1: Advanced or Refractory Solid Tumours Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer

Start date: 2013-04-01
Primary completion: 2021-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.